Logo image of GELS

GELTEQ LTD (GELS) Stock Price, Quote, News and Overview

NASDAQ:GELS - Nasdaq - AU0000218109 - Common Stock - Currency: USD

2.66  -0.22 (-7.64%)

Premarket: 2.42 -0.24 (-9.02%)

GELS Quote, Performance and Key Statistics

GELTEQ LTD

NASDAQ:GELS (4/23/2025, 8:09:36 PM)

Premarket: 2.42 -0.24 (-9.02%)

2.66

-0.22 (-7.64%)

Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
Statistics
52 Week HighN/A
52 Week LowN/A
Market Cap25.11M
Shares9.44M
Float3.74M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPO10-29 2024-10-29


GELS short term performance overview.The bars show the price performance of GELS in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 50 100 150

GELS long term performance overview.The bars show the price performance of GELS in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of GELS is 2.66 USD. In the past month the price increased by 150.94%.

GELTEQ LTD / GELS Daily stock chart

GELS Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO 63.8 786.28B
JNJ JOHNSON & JOHNSON 15.46 374.44B
NVO NOVO-NORDISK A/S-SPONS ADR 17.67 272.11B
NVS NOVARTIS AG-SPONSORED ADR 13.87 217.52B
AZN ASTRAZENECA PLC-SPONS ADR 16.51 212.41B
MRK MERCK & CO. INC. 10.31 198.14B
SNY SANOFI-ADR 11.83 129.80B
PFE PFIZER INC 7.2 126.98B
BMY BRISTOL-MYERS SQUIBB CO 42.57 98.75B
GSK GSK PLC-SPON ADR 8.51 75.03B
ZTS ZOETIS INC 25.49 67.31B
TAK TAKEDA PHARMACEUTIC-SP ADR 32.3 47.78B

About GELS

Company Profile

Gelteq Ltd. is a biotechnology company. The company is headquartered in Melbourne, Victoria and currently employs 7 full-time employees. The company went IPO on 2024-10-29. The firm is focused on developing and commercializing white-label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products. The firm offers a complete end-to-end service for the development of new products and the conversion of existing products and formulations into gels. Its product suite consists of multiple products that sit within five core verticals - for pets, sports, pharmaceuticals (pharma), over-the-counter (OTC) and nutraceuticals. The Company’s delivery system provides pharma and nutraceutical enhancements throughout every stage of ingestion in both animals and humans, addressing the complete experience from the point of ingestion to final absorption. The firm also offers a highly versatile portfolio of pre-tested and market-ready proprietary formulations that can be white-labelled.

Company Info

GELTEQ LTD

Level 4, 100 Albert Road

Melbourne VICTORIA AU

Employees: 7

Company Website: https://www.gelteq.com

Investor Relations: https://ir.gelteq.com/

Phone: 61390873990

GELTEQ LTD / GELS FAQ

What is the stock price of GELTEQ LTD today?

The current stock price of GELS is 2.66 USD. The price decreased by -7.64% in the last trading session.


What is the ticker symbol for GELTEQ LTD stock?

The exchange symbol of GELTEQ LTD is GELS and it is listed on the Nasdaq exchange.


On which exchange is GELS stock listed?

GELS stock is listed on the Nasdaq exchange.


What is GELTEQ LTD worth?

GELTEQ LTD (GELS) has a market capitalization of 25.11M USD. This makes GELS a Nano Cap stock.


How many employees does GELTEQ LTD have?

GELTEQ LTD (GELS) currently has 7 employees.


What are the support and resistance levels for GELTEQ LTD (GELS) stock?

GELTEQ LTD (GELS) has a resistance level at 2.89. Check the full technical report for a detailed analysis of GELS support and resistance levels.


Should I buy GELTEQ LTD (GELS) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does GELTEQ LTD (GELS) stock pay dividends?

GELS does not pay a dividend.


What is the Price/Earnings (PE) ratio of GELTEQ LTD (GELS)?

GELTEQ LTD (GELS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.24).


What is the Short Interest ratio of GELTEQ LTD (GELS) stock?

The outstanding short interest for GELTEQ LTD (GELS) is 0.19% of its float. Check the ownership tab for more information on the GELS short interest.


GELS Technical Analysis

ChartMill assigns a technical rating of 4 / 10 to GELS.


Chartmill TA Rating
Chartmill Setup Rating

GELS Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to GELS. Both the profitability and financial health of GELS have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

GELS Financial Highlights

Over the last trailing twelve months GELS reported a non-GAAP Earnings per Share(EPS) of -0.24. The EPS decreased by -1.13% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -17.08%
ROE -23.47%
Debt/Equity 0.12
Chartmill High Growth Momentum
EPS Q2Q%-19.62%
Sales Q2Q%N/A
EPS 1Y (TTM)-1.13%
Revenue 1Y (TTM)-100%

GELS Ownership and Analysts


Ownership
Inst Owners0.86%
Ins Owners48.88%
Short Float %0.19%
Short Ratio0.03
Analysts
AnalystsN/A
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A